Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
This guide demonstrates how to leverage historical returns to shape retirement-index-fund allocations and risk management.
21,926 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A diversified ETF bundles 38 clean-energy names into a single exposure, aiming for long-term growth as policy timelin...
Institutions are back in force for Bitcoin, led by US Bitcoin ETFs and MicroStrategy buying. Flows total about $1.25B...
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...
Bitcoin hovers near $74,000 as market eyes Powell and the Fed. An analyst warns of a repeat sell-the-news pattern, ev...
When a chief operating officer sells shares, investors often wonder what it really means. This guide explains how to ...
As a global health scare rises in prominence, investors quiz whether bitcoin can withstand another black swan shock. ...
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
Harvard's endowment has sold its entire Ethereum stake after a short-lived bet, marking another reset in its crypto s...
The Las Vegas Strip bid farewell to a family-driven dining concept after almost four years. This article breaks down ...
SpaceX aims for the largest IPO in history, targeting a $135-per-share price and up to $75 billion in proceeds. Durin...
Ripple (XRP) has fallen about 38% in 2026, trading near $1 as Bitcoin and Ethereum drag the market lower. Analysts wa...